Outcome after second autologous stem cell transplantation as salvage therapy in patients with relapsed multiple myeloma.

被引:5
|
作者
Mikhael, JR [1 ]
Samiee, S [1 ]
Stewart, AK [1 ]
Chen, C [1 ]
Trudel, S [1 ]
Franke, N [1 ]
Winter, A [1 ]
Chang, H [1 ]
Reece, DE [1 ]
机构
[1] Princess Margaret Hosp, Hematol Lab, Toronto, ON M4X 1K9, Canada
关键词
D O I
10.1182/blood.V104.11.943.943
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
943
引用
收藏
页码:270A / 270A
页数:1
相关论文
共 50 条
  • [41] Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation
    Ikeda, Takashi
    Mori, Keita
    Kawamura, Koji
    Mori, Takehiko
    Hagiwara, Shotaro
    Ueda, Yasunori
    Kahata, Kaoru
    Uchida, Naoyuki
    Tsukada, Nobuhiro
    Murakami, Satoshi
    Yamamoto, Masahide
    Takahashi, Tsutomu
    Ichinohe, Tatsuo
    Onizuka, Makoto
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    Okamoto, Shinichiro
    Sunami, Kazutaka
    Takamatsu, Hiroyuki
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (05) : 586 - 594
  • [42] Second Autologous Stem Cell Transplant: An Effective Therapy for Relapsed Multiple Myeloma
    Abbi, Kamal Kant Singh
    Zheng, Junting
    Devlin, Sean M.
    Giralt, Sergio
    Landau, Heather
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 468 - 472
  • [43] Natural history of relapse after autologous stem cell transplantation for multiple myeloma.
    McClune, B
    Buadi, F
    Yunus, F
    Minhas, S
    Walsh, W
    Przepiorka, D
    BLOOD, 2005, 106 (11) : 466B - 466B
  • [44] LONG TERM CRYOPRESERVED AUTOLOGOUS BLOOD STEM CELLS FOR SALVAGE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN RELAPSED MULTIPLE MYELOMA PATIENTS
    Areethamsirikul, N.
    Mashi-Khan, E.
    Winter, A.
    Jimenez-Zepeda, V.
    Reece, D. E.
    Chen, C.
    Trudel, S.
    Tiedemann, R.
    Kukreti, V.
    HAEMATOLOGICA, 2014, 99 : 369 - 369
  • [45] Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma
    Christopher Lemieux
    Lori S. Muffly
    David J. Iberri
    Juliana K. Craig
    Laura J. Johnston
    Robert Lowsky
    Parveen Shiraz
    Andrew R. Rezvani
    Matthew J. Frank
    Wen-Kai Weng
    Everett Meyer
    Judith A. Shizuru
    Sally Arai
    Michaela Liedtke
    Robert S. Negrin
    David B. Miklos
    Surbhi Sidana
    Bone Marrow Transplantation, 2021, 56 : 2664 - 2671
  • [46] Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma
    Lemieux, Christopher
    Muffly, Lori S.
    Iberri, David J.
    Craig, Juliana K.
    Johnston, Laura J.
    Lowsky, Robert
    Shiraz, Parveen
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett
    Shizuru, Judith A.
    Arai, Sally
    Liedtke, Michaela
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2664 - 2671
  • [47] Salvage second transplantation in relapsed multiple myeloma
    Binod Dhakal
    Anita D’Souza
    Ariel Kleman
    Saurabh Chhabra
    Meera Mohan
    Parameswaran Hari
    Leukemia, 2021, 35 : 1214 - 1217
  • [48] Salvage second transplantation in relapsed multiple myeloma
    Dhakal, Binod
    D'Souza, Anita
    Kleman, Ariel
    Chhabra, Saurabh
    Mohan, Meera
    Hari, Parameswaran
    LEUKEMIA, 2021, 35 (04) : 1214 - 1217
  • [49] Outcomes of Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Meta-Analysis
    Dadi, Neelakanta
    Vosuri, Venkata
    Master, Samip R.
    Mansour, Richard Preston
    BLOOD, 2019, 134
  • [50] Novel agent-based salvage autologous stem cell transplantation for relapsed multiple myeloma
    Zannetti, Beatrice Anna
    Tacchetti, Paola
    Pantani, Lucia
    Gamberi, Barbara
    Tosi, Patrizia
    Rocchi, Serena
    Cellini, Claudia
    Ronconi, Sonia
    Pezzi, Annalisa
    Mancuso, Katia
    Rizzello, Ilaria
    Caratozzolo, Isola
    Martello, Marina
    Dozza, Luca
    Cavo, Michele
    Zamagni, Elena
    ANNALS OF HEMATOLOGY, 2017, 96 (12) : 2071 - 2078